Pura Vida Investments

Pura Vida Investments, operating under the Pura Vida Funds umbrella, is a New York-based investment manager with a specialized focus on the global healthcare sector. The firm employs a multi-strategy approach, managing both public equity (long/short) funds and dedicated private equity vehicles. Their private equity arm specifically targets growth equity and buyout opportunities within healthcare, encompassing areas like biotechnology, pharmaceuticals, medical devices, and healthcare services, demonstrating a comprehensive understanding of the industry's diverse sub-sectors.

Pura Vida has demonstrated significant capital-raising capabilities, successfully closing two dedicated private equity funds. Pura Vida Private Equity Fund I closed in 2019 with $150 million in commitments, followed by the larger Pura Vida Private Equity Fund II, which closed in 2021 with $350 million. This substantial capital base underscores their commitment and capacity for deploying significant capital into healthcare companies, positioning them as a notable player in the sector's private investment landscape.

The firm's private equity strategy is centered on identifying and partnering with innovative healthcare companies poised for growth or requiring strategic capital for buyouts. While specific check sizes can vary based on the opportunity and stage, Pura Vida typically deploys initial investments ranging from approximately $15 million for growth equity rounds to up to $50 million for larger growth equity or smaller buyout transactions. They seek to be value-add partners, leveraging their deep industry expertise and network to support portfolio companies through various stages of development, with an investment thesis rooted in a thorough understanding of healthcare market trends, regulatory landscapes, and technological advancements.